Trials / Completed
CompletedNCT04209426
Retrospective Observational Cohort Study of SYMBOL CUP DM 2
Etude de Cohorte Observationnelle Rétrospective SYMBOL CUP 2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Dedienne Sante S.A.S. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center retrospective observational cohort study of consecutively operated patients who underwent total hip arthroplasty (THA) with a SYMBOL CUP DMR HA or a SYMBOL CUP DM CEM hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of those two implants at two-year follow-up.
Detailed description
Description according to PICOS (Patient, Intervention, Comparator, Outcomes, Study design) framework: Patients: \- Adult men and women requiring a total hip arthroplasty Intervention: \- THA with SYMBOL CUP DMR HA or SYMBOL CUP DM CEM hemispherical dual mobility acetabular implants. Comparator: None Outcomes: * Safety 1: Implant survival over 2-year follow-up. * Safety 2: All adverse events, with focus on implant dislocation, infections, revision surgery * Efficacy 1: Harris Hip Score (HHS) at baseline and 1-year follow-up. * Efficacy 2: Modified HHS (mHHS) consisting of pain + functional subscores at baseline, 1-year and 2-year follow-ups. * Efficacy 2: Devane score at baseline, 1-year and 2-year follow-ups. * Efficacy 3: Charnley classification at baseline, 1-year and 2-year followups. Study design: * single-center retrospective observational cohort study of consecutively operated patients who underwent total hip arthroplasty 2 years prior to study start. * Prospective 2-year follow-up letter and phone questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | THA with SYMBOL CUP DMR HA | |
| DEVICE | THA with SYMBOL CUP DM CEM |
Timeline
- Start date
- 2015-03-18
- Primary completion
- 2018-03-31
- Completion
- 2018-08-14
- First posted
- 2019-12-24
- Last updated
- 2025-04-18
- Results posted
- 2025-04-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04209426. Inclusion in this directory is not an endorsement.